Related Experiment Videos
Informed consent for investigational chemotherapy: patients' and physicians' perceptions
Summary
Patients often trust physician advice during chemotherapy consent, with many feeling their decision-making participation was limited. This impacts patient autonomy in clinical trial enrollment.
Area of Science:
- Oncology
- Clinical Trials
- Bioethics
Background:
- Informed consent is crucial for patient autonomy in clinical research.
- Understanding patient and physician perceptions of the consent process is vital for ethical trial conduct.
Purpose of the Study:
- To investigate patient and physician perceptions of the chemotherapy investigational protocol consent procedure.
- To identify factors influencing patient decision-making and autonomy during consent.
Main Methods:
- A study involving 144 patients and 68 physicians across three cancer centers.
- Data collection focused on perceptions of a consent procedure for chemotherapy investigational protocols conducted 1-3 weeks prior.
Main Results:
- Patients generally recalled the consent procedure positively, relying heavily on physician advice.
- 29% of patients felt their participation in decision-making was not encouraged; nearly a fourth did not recall the investigational nature of the treatment.
- Physicians perceived many patients as passive or avoidant of treatment details, potentially limiting patient autonomy.
Conclusions:
- Both patient and physician perceptions can inadvertently constrain patient autonomy in decision-making during clinical trial consent.
- Enhancing patient engagement and recall of critical information is necessary for truly informed consent in oncology research.